Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Vivo Opportunity, LLC Insider Profile
4 Followers
Vivo Opportunity, LLC, Director, Ten Percent Owner at Sierra Oncology, holds 6.24M shares in Terns Pharmaceuticals (Ticker: TERN), holds 8.42M shares in Soleno Therapeutics (Ticker: SLNO), holds 0.00 shares in Sierra Oncology (Ticker: SRRA).
Vivo Opportunity, LLC Sierra Oncology (SRRA)Director, Ten Percent Owner
Sierra Oncology (SRRA)
Director, Ten Percent Owner
Ranked #12,135 out of 97,948 Corporate Insiders
Profitable Transactions
4 out of 5 Profitable Transactions
Average Return
+29.20%
Average return per transaction
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that Vivo Opportunity, LLC holds in companies
Most Profitable Insider Trade
The most profitable trade made by Vivo Opportunity, LLC
Vivo Opportunity, LLC's Trading History
Sierra Oncology
Jul 01, 2022
―
Uninformative Sell
183.12M
$0.00
Terns Pharmaceuticals
Apr 03, 2024
Ten Percent Owner
Uninformative Sell
2.80M
$37.42M
Soleno Therapeutics
Oct 04, 2023
Ten Percent Owner
Informative Buy
13.04M
$351.54M
List of latest transactions for each holding click on a transaction to see Vivo Opportunity, LLC's performance on stock
You May Also Like
Vivo Opportunity, LLC insider profile FAQ
What is the percentage of profitable transactions made by Vivo Opportunity, LLC?
The percentage of profitable transactions made by Vivo Opportunity, LLC is 80%.
What is the average return per transaction made by Vivo Opportunity, LLC?
The average return per transaction made by Vivo Opportunity, LLC is 29.20%.
What stocks does Vivo Opportunity, LLC hold?
Vivo Opportunity, LLC holds: SRRA, TERN, SLNO stocks.
What was Vivo Opportunity, LLC’s latest transaction?
Vivo Opportunity, LLC latest transaction was an Uninformative Sell of $2.80M.
What was Vivo Opportunity, LLC's most profitable transaction?
Vivo Opportunity, LLC’s most profitable transaction was an Informative Buy of SLNO stock on October 4, 2023. The return on the trade was 68.70%.
What is Vivo Opportunity, LLC's role in Sierra Oncology?
Vivo Opportunity, LLC's role in Sierra Oncology is Director, Ten Percent Owner.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.